Cosmos Health Receives Initial Orders Exceeding $500,000 For C-Scrub In The UK; Future Orders Booked At Accelerated Pace With Strong Profitability Anticipated Due To High Profit Margins
Cosmos Health Receives Initial Orders Exceeding $500,000 For C-Scrub In The UK; Future Orders Booked At Accelerated Pace With Strong Profitability Anticipated Due To High Profit Margins
Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has received its first round of purchase orders in the United Kingdom (UK) for its antimicrobial wash, C-Scrub Wash Chlorhexidine 4% ('C-Scrub'), exceeding $500,000. The orders cover the period from July 2024 to September 2024.
阿童木健康公司（"阿童木健康" 或 "公司''） （納斯達克：COSM），一個多元化、垂直整合的全球醫療集團，致力於創新研發，擁有專有藥品和營養品品牌，生產和分銷醫療產品，並經營一家遠程醫療平台。今天宣佈，該公司已收到在英國（英國）購買其抗菌洗滌液C-Scrub 氯己定4% ('C-Scrub') 的首批訂購，訂單金額超過50萬美元。這些訂單涵蓋了2024年7月至2024年9月的區間。
Cosmos Health is in the process of securing additional orders for October 2024 and beyond. Given the high profit margins associated with C-Scrub, the Company anticipates substantial profitability from these orders. The shipments will supply various entities in the UK as part of the Company's comprehensive sales strategy, targeting a diverse range of customers, including hospitals and wholesalers. Additionally, the Company reaches consumers directly through its online stores on platforms such as Amazon, TikTok, and eBay.
阿童木健康正在努力確保在2024年10月及以後獲得額外訂單。鑑於C-Scrub 帶來的高利潤率，公司預計將從這些訂單中獲得可觀的利潤。這些貨物將供應英國的各個單位，作爲公司全面銷售策略的一部分，針對多樣化的客戶群，包括醫院和批發商。此外，公司還通過亞馬遜、TikTok 和 ebay 等平台的在線商店直接接觸消費者。
譯文內容由第三人軟體翻譯。